Skip to content

    Recently Viewed

      Listening...

      Home /
      Johnson & Johnson Consumer Inc. Presents 21 Scientific Posters/Abstracts At The 2017 American Academy of Dermatology Annual Meeting

      Johnson & Johnson Consumer Inc. Presents 21 Scientific Posters/Abstracts At The 2017 American Academy of Dermatology Annual Meeting

      Neonatal Microbiome Study to be Presented at Late-Breaking Research Forum

      Share Article
      share to

      SKILLMAN, N.J., March 3, 2017 -- As a global leader in scientifically driven skincare, Johnson & Johnson Consumer Inc. will present 21 Posters/Abstracts at this year’s American Academy of Dermatology (AAD) Annual Meeting in Orlando, FL, March 3-7, 2017. The research includes studies in photoprotection, light therapy for acne, atopic dermatitis and skin microbiome.

      “As the research shared at this meeting shows, our scientists study skin health around the world and across a lifetime, from birth to maturity,” said Jennifer Zhu, Vice President, Global Beauty R&D at Johnson & Johnson Consumer Inc. “We are committed to developing transformative solutions for common skincare concerns, while adhering to a high standard of clinical efficacy and superior aesthetics.”

      “Our team is committed to better understanding the role of the microbiome across skin health in a scientifically rigorous way in order to provide truly disruptive approaches to treating skin issues,” said Ms. Zhu. “This area of research delivers insights that are relevant to our current business, as well as to our long-term pipeline for both pediatric and adult product development.”

      Scientific Posters include evaluations of high-SPF sunscreen in real-world settings, as well as an assessment of efficacy, tolerance and mode of action for low-level blue/red light therapy in treatment of acne.

      All abstracts will be available for online viewing at the AAD meeting starting 7:00AM EST on March 3, 2017.


      Photoprotection: including sunscreen efficacy in actual use settings, Zinc
      Oxide technology, anti-aging benefits


      #4389

      High-SPF Sunscreen Provides Significant Clinical Benefit in Actual-Use
      Conditions: SPF 100+ Is More Effective Than SPF 50+



      #4388

      High-SPF Sunscreen Provides Significantly Better Sunburn Protection
      and Reduces Cumulative Skin Damage During a MultiDay Beach
      Clinical Study: SPF 100+ Is More Effective Than SPF 50+



      #4440

      Sun Protection Efficacy by Shade



      #4439

      Modern Sunscreen Formulations Do Not Interfere with Sweating
      During Exercise



      #4458

      Microscopic Evaluation of ZnO Sunscreens In Vivo



      #4438

      Zinc Oxide Technology and Superior UVA Protection



      #4501

      Objective and Self-Perceived Anti-Aging Skin Benefits Using a Daily
      Facial Photostable, Broad-Spectrum Sunscreen Product Over One Year
      on Asian Subjects





      Acne: including low-level red/blue light therapy, cleansing and skin barrier


      #4436

      A Multicenter, Evaluator-Blinded, Randomized Clinical Study to
      Evaluate the Efficacy and Tolerance of Two Acne Treatments on
      Subjects with Mild to Moderate Acne Vulgaris



      #4441

      Low-Level Red LED Light Inhibits Inflammation Induced by
      Unsaturated Fatty Acid In Vitro



      #4377

      Utilization of 440 nm Blue Light to Target Propionibacterium acnes for
      Treating Acne Vulgaris



      #5651

      Dermatologists’ Perceptions of Blue-Red Light Acne Phototherapies



      #5560

      Physicians’ Attitudes Toward Home-based Devices for Acne



      #4402

      Efficacy and Skin Barrier Benefits of a Novel Acne Cleanser with
      Polymeric Surfactant Technology



      Atopic Dermatitis and Severe Dry Skin


      #4390

      A Clinical Trial to Determine the Therapeutic Benefit of an
      Investigational Over-the-Counter Cream on Dry, Itchy Skin of Adults
      and Children with Atopic Dermatitis



      #4391

      Compliance Usage Rate and Efficacy of a Coconut-Scented Lotion
      Versus a Fragrance-Free Lotion in Female Subjects with Moderate to
      Severe Dry Skin With Itch



      #4392

      A Clinical Trial to Evaluate the Efficacy of an OTC Colloidal Oatmeal Skin Protectant
      Cream in the Management of Mild to Moderate Atopic Dermatitis in Infants and Toddlers



      Hydration and Skin Barrier


      #4442

      A Unique Gel Matrix Moisturizer Delivers Deep Hydration Resulting in
      Significant Clinical Improvement in Radiance and Texture





      Aesthetic Dermatology


      #5127

      A Multifaceted Calming Serum Significantly Improves Facial Redness and Signs of Aging
      in Combination with a PHA/Bionic Acid Skincare Regimen



      #5568

      A Topical Effervescent Mask Provides Oxygen with Polyhydroxy/Bionic Acids to Help
      Calm Skin Immediately After Non- Invasive Cosmetic Procedures



      #5118

      Advanced, Physician-Strength Retinol Peel Improves the Appearance of Fine Lines,
      Wrinkles, Skin Firmness and Overall Complexion Brightness

      About Johnson & Johnson Consumer Inc.
      Johnson & Johnson Consumer Inc., based in Skillman, NJ, is one of the world’s largest consumer health and personal care products companies. Our consumer companies produce many of the world’s most trusted brands, among them JOHNSON’S® Baby, BAND-AID®, NEUTROGENA®, TYLENOL®, MOTRIN®, and LISTERINE®. Each one of our consumer businesses embraces innovative science to create products that anticipate consumer needs and create experiences that help them live healthy, vibrant lives.

      Media Contacts:
      Toneisha Friday
      (908) 938-9146
      tfriday3@its.jnj.com

      John Lacey
      (781) 392-5514
      jlacey1@its.jnj.com

      You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.